ArticleAfrican journal of primary health care & family medicine2026
Oral iron supplementation as a public health intervention in children aged 6 to 23 months for preventing iron deficiency and anaemia: Economic evaluation for the South African health system.
Article in African journal of primary health care & family medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnaemia prevalence among Southern African children aged 6-23 months was estimated at 65% in 2019. The World Health Organization recommends that children aged 6-23 months living in countries with an anaemia prevalence above 40% should receive preventive oral iron supplements.
aimThis study aimed to conduct a context-specific economic evaluation of oral iron supplementation in children aged 6 months - 23 months for preventing iron deficiency and anaemia in South Africa (SA).
methodWe undertook a cost-effectiveness analysis (CEA), comparing preventive iron supplementation with no supplementation. Using a 1-year time horizon, we took a provider perspective and used circulating haemoglobin as the effectiveness outcome. The incremental cost-effectiveness ratio (ICER) was calculated as the cost per disability-adjusted life year (DALY) because of anaemia averted. A budget impact analysis (BIA) was carried out to estimate start-up and total annual costs of intervention implementation in SA.
resultsThe ICER (cost per DALY averted) was R1077.00 ($58.40); below a conservative context-relevant threshold (R62 916.00 [$3410.00]) (2024). Budget impact analysis estimated total costs over 2 years (2024-2025), excluding start-up costs, of R16.94 ($0.92) per child aged 2 years in SA, based on the CEA dosing regimen. Intervention costs (including start-up costs) represent 0.007% of the total health budget (2024).
conclusionPreventive oral iron supplementation resulted in increased effectiveness for averting DALYs because of anaemia. Comparisons of the ICER with context-relevant thresholds suggested the intervention could be considered cost-effective in SA.Contribution: Our findings of potential cost-effectiveness and budget impact could be used to inform decision-making for primary healthcare resource allocation in SA's health system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.